|
|
|
Volumn 34, Issue 5, 1989, Pages 347-352
|
|
Clinical evidence of the minimal androgenic activity of norgestimate
a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROGEN;
ETHINYLESTRADIOL;
ETHINYLESTRADIOL PLUS LEVONORGESTREL;
ETHINYLESTRADIOL PLUS NORGESTREL;
LIPOPROTEIN;
NORGESTIMATE;
ACNE;
BODY WEIGHT;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
PRIORITY JOURNAL;
ANDROGENS--ANALYSIS;
BIOLOGY;
CLINICAL RESEARCH;
COMPARATIVE STUDIES;
CONTRACEPTION;
CONTRACEPTION CONTINUATION;
CONTRACEPTION TERMINATION;
CONTRACEPTIVE METHODS;
CONTRACEPTIVE USAGE;
ENDOCRINE SYSTEM;
EVALUATION;
EXAMINATIONS AND DIAGNOSES;
FAMILY PLANNING;
HORMONES;
LABORATORY EXAMINATIONS AND DIAGNOSES;
LIPID METABOLIC EFFECTS--ANALYSIS;
LIPIDS;
METABOLIC EFFECTS;
ORAL CONTRACEPTIVES;
ORAL CONTRACEPTIVES, COMBINED;
PHYSIOLOGY;
RESEARCH METHODOLOGY;
STEROID METABOLIC EFFECTS--ANALYSIS;
STUDIES;
ACNE VULGARIS;
ADULT;
ANDROGEN-BINDING PROTEIN;
ANDROGENS;
COMPARATIVE STUDY;
CONTRACEPTIVES, ORAL, COMBINED;
ETHINYL ESTRADIOL;
FEMALE;
HUMAN;
LIPOPROTEINS;
MULTICENTER STUDIES;
NORGESTREL;
RANDOMIZED CONTROLLED TRIALS;
WEIGHT GAIN;
|
|
EID: 0024425684
PISSN: 0020725X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (64)
|
|
References (0)
|